good question.
i assume that when they designed the trial they assumed MTD would be 12GBq. Dose limitations have not yet been reached, and suggested that a further cohort increasing the dose should be used.
Lets see what happens after cohort 4 expansion comes in for Secure.
I was also thinking whether there are any limitations for the manufacture of isotope / cage start to degrade if they go above 12+ GBq?
I will happily read between the lines that cu67 is working better than hoped thus MTD not yet reached.
Research/Valuation, page-206
-
- There are more pages in this discussion • 332 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.20 |
Change
0.170(3.38%) |
Mkt cap ! $1.620B | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.22 | $5.04 | $5.857M | 1.137M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4869 | $5.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.21 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |